Skip to content
Resources > Reports

Healthcare 2026 Industry Outlook: A Year of Necessary Transformation

By Sara Mallatt, Director of Healthcare Research
IndustryLife Sciences & Healthcare

The global healthcare industry is at an inflection point, moving from a year of defensive maneuvering to one that requires strategic transformation. In 2025, healthcare companies were forced to react to many immediate, high-magnitude threats. The pressures of 2025 suggest that in 2026 the healthcare industry will need to shift toward structural changes that ensure long-term prosperity.

While 2025 was a period of diagnosis and defense, 2026 will likely be a year of execution and fundamental transformation as firms race to ensure long-term financial viability. Drawing on Tegus Expert Insights and other proprietary intelligence in AlphaSense, this report maps the critical path to that transformation.

About the Author

  • Sara Mallatt, Director of Healthcare Research

    Sara has more than 18 years of experience generating sell-side research content across a variety of industries. Prior to joining AlphaSense, Sara held leadership positions at OTR Global, a leading channel research firm, most recently as Director of Healthcare Research. Sara holds a bachelor’s degree in journalism and a master’s in industrial engineering. She works from her home in Missoula, Montana.

Explore more

All articles

APAC Macro Briefing 2026: Risk Meets Opportunity

In this report, we show how resources and workflows available in the AlphaSense platform can help contextualize the APAC macro environment, exploring the key implications for corporate leaders and investors across sectors.
Report
Title slide for "APAC Macro Briefing 2026: Risk Meets Opportunity" with a map of the Asia-Pacific region.

Top AI Use Cases for Private Equity

In this report, discover how private equity teams are leveraging AI to accelerate conviction with speed. With purpose built, AI-driven solutions like AlphaSense, teams are gaining a competitive advantage with custom workflows and unmatched content sets for the most differentiated deal intelligence.
Report
Top AI Use Cases For Private Equity by Barb Tague, Financial Research Leader. Illustration featuring isometric buildings and currency symbols.

AI in Drug Development 2026: From Experimentation to Execution

Learn how AI is reshaping drug development in real time, turning AI execution into a key competitive differentiator.
Report
Presentation slide titled "AI in Drug Development 2026: From Experimentation to Execution" by Sara Mallatt and Sean Carmichael, with line art of laboratory equipment.

Transform intelligence
into advantage

Develop bold strategies, seize opportunities,
and lead with clarity and confidence.